GPAT
Income statement / Annual
Last year (2024), GP-Act III Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, GP-Act III Acquisition Corp.'s net income was $8.67 M.
See GP-Act III Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$564.97 K
|
$14.04 K
|
$30.84 K
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$564.97 K
|
$14.04 K
|
$30.84 K
|
$3.97 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$564.97 K
|
$14.04 K
|
$30.84 K
|
$3.97 K
|
| Cost And Expenses |
$564.97 K
|
$14.04 K
|
$30.84 K
|
$3.97 K
|
| Interest Income |
$9.24 M
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$30.84 K
|
$0.00
|
| EBITDA |
$8.67 M |
-$14.04 K |
$0.00 |
-$3.97 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$9.24 M
|
$0.00
|
$0.00
|
-$3.00
|
| Income Before Tax |
$8.67 M
|
-$14.04 K
|
-$30.84 K
|
-$3.97 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
$8.67 M
|
-$14.04 K
|
-$30.84 K
|
-$3.97 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
| EPS |
0.24 |
-0.0004 |
-0.001 |
-0.0001 |
| EPS Diluted |
0.47 |
-0.0004 |
-0.001 |
-0.0001 |
| Weighted Average Shares Out |
$35.94 M
|
$31.25 M
|
$31.25 M
|
$31.25 M
|
| Weighted Average Shares Out Diluted |
$18.30 M
|
$31.25 M
|
$31.25 M
|
$31.25 M
|
| Link |
|
|
|
|
